Gene Expression Analysis Market Report by Products & Services, Technology (Polymerase Chain Reaction, Next Generation Sequencing, DNA Microarray, Sanger Sequencing, and Others), Capacity, End-User, and Region 2024-2032
세계 유전자 발현 분석 시장 규모는 2023년 51억 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장 규모가 110억 달러에 달해 2024-2032년 사이 8.6%의 연평균 성장률(CAGR)을 기록할 것으로 예측했습니다.
유전자 발현 분석(GEA)은 생물학적 시스템의 거동을 조사하기 위해 유전자에서 데이터를 추출하는 방법입니다. 유전자 발현 분석에는 유전자 전사, 번역, 단백질의 번역 후 변형, RNA 스플라이싱 등 다양한 과정이 포함됩니다. 이 분석을 통해 얻은 데이터는 단백질, 리보핵산(RNA), 다양한 미생물학적 산물의 생산에 활용됩니다. GEA는 현재 약리유전체학, 바이오마킹, 독성학, 진단학에 광범위하게 응용되고 있으며, 많은 의료 질환의 원인 메커니즘을 설명하는 데 필수적인 것으로 널리 알려져 있습니다.
맞춤형 의료에 대한 수요 증가와 함께 표적 분자 치료의 채택이 증가하고 있는 것도 시장 성장의 주요 요인 중 하나이며, GEA는 분자생물학 연구에서 강력한 도구로 입증되어 유전자 기능을 이해하고, 질병을 진단하고, 의약품 개발을 촉진하는 데 사용되고 있습니다. 사용되고 있습니다. 또한 암, 결핵, 심혈관 질환, 유전성 질환과 같은 만성 질환의 유병률 증가는 시장 성장을 크게 촉진하고 있습니다. 또한, 이러한 질병을 치료하기 위한 맞춤형 의약품의 개발로 인해 환자 개개인의 요구에 따라 진단 및 치료법을 변경할 수 있게 되었습니다. 또한, 차세대 염기서열 분석(NGS)의 등장, 유전체 데이터베이스의 개발, GEA의 성공률 향상, 유전자 치료 연구개발(R&D)에 대한 집중 강화 등 다양한 기술 발전이 시장 성장을 더욱 촉진할 것으로 예상됩니다.
본 보고서에서 다루는 주요 질문들
- 세계 유전자 발현 분석 시장 규모는?
- 2024-2032년 세계 유전자 발현 분석 시장의 예상 성장률은?
- 유전자 발현 분석 세계 시장을 이끄는 주요 요인은 무엇인가?
- COVID-19가 전 세계 유전자 발현 분석 시장에 미친 영향은?
- 유전자 발현 분석 세계 시장에서의 제품 및 서비스별 구분은?
- 유전자 발현 분석 세계 시장에서의 기술별 구분은?
- 유전자 발현 분석 세계 시장 생산능력별 구분은?
- 유전자 발현 분석 세계 시장을 최종사용자별로 분류하면?
- 유전자 발현 분석 세계 시장 주요 지역은?
- 유전자 발현 분석 세계 시장 주요 진출 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 유전자 발현 분석 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품 및 서비스별
제7장 시장 내역 : 기술별
- 중합효소 연쇄 반응(PCR)
- 차세대 시퀸싱(NGS)
- DNA 마이크로어레이
- 생어 시퀀싱
- 기타
제8장 시장 내역 : 생산능력별
- 중저 플렉스 유전자 발현 분석
- 고플렉스 유전자 발현 분석
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
- 북미
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 칠레
- 페루
- 기타
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
- 개요
- 인바운드 물류
- 오퍼레이션
- 아웃바운드 물류
- 마케팅과 세일즈
- 서비스
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제14장 가격 지표
제15장 경쟁 상황
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Agilent Technologies, Inc.
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- Eurofins GSC Lux SARL
- F. Hoffmann-La Roche Ltd
- GE Healthcare
- Illumina, Inc.
- Oxford Gene Technology IP Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN GmbH
- Thermo Fisher Scientific Inc.
ksm
The global gene expression analysis market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.
Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.
The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gene expression analysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on products & services, technology, capacity and end-user.
Breakup by Products & Services:
Consumables
Instruments
Services
Breakup by Technology:
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
DNA Microarray
Sanger Sequencing
Others
Breakup by Capacity:
Low-to Mid-Plex Gene Expression Analysis
High-Plex Gene Expression Analysis
Breakup by End-User:
Pharmaceutical and Biotech Companies
Academic Institutes and Research Centers
Others
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.
Key Questions Answered in This Report
- 1. How big is the global gene expression analysis market?
- 2. What is the expected growth rate of the global gene expression analysis market during 2024-2032?
- 3. What are the key factors driving the global gene expression analysis market?
- 4. What has been the impact of COVID-19 on the global gene expression analysis market?
- 5. What is the breakup of the global gene expression analysis market based on the product & services?
- 6. What is the breakup of the global gene expression analysis market based on the technology?
- 7. What is the breakup of the global gene expression analysis market based on the capacity?
- 8. What is the breakup of the global gene expression analysis market based on the end-user?
- 9. What are the key regions in the global gene expression analysis market?
- 10. Who are the key players/companies in the global gene expression analysis market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gene Expression Analysis Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact Of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Products & Services
- 6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Next Generation Sequencing (NGS)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 DNA Microarray
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Sanger Sequencing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Capacity
- 8.1 Low-to Mid-Plex Gene Expression Analysis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 High-Plex Gene Expression Analysis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Pharmaceutical and Biotech Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Academic Institutes and Research Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Europe
- 10.2.1 Germany
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 France
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 United Kingdom
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 Italy
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Spain
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Russia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Asia-Pacific
- 10.3.1 China
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 Japan
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 India
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 South Korea
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Australia
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Indonesia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Argentina
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.4 Colombia
- 10.4.4.1 Market Trends
- 10.4.4.2 Market Forecast
- 10.4.5 Chile
- 10.4.5.1 Market Trends
- 10.4.5.2 Market Forecast
- 10.4.6 Peru
- 10.4.6.1 Market Trends
- 10.4.6.2 Market Forecast
- 10.4.7 Others
- 10.4.7.1 Market Trends
- 10.4.7.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Turkey
- 10.5.1.1 Market Trends
- 10.5.1.2 Market Forecast
- 10.5.2 Saudi Arabia
- 10.5.2.1 Market Trends
- 10.5.2.2 Market Forecast
- 10.5.3 Iran
- 10.5.3.1 Market Trends
- 10.5.3.2 Market Forecast
- 10.5.4 United Arab Emirates
- 10.5.4.1 Market Trends
- 10.5.4.2 Market Forecast
- 10.5.5 Others
- 10.5.5.1 Market Trends
- 10.5.5.2 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
- 12.1 Overview
- 12.2 Inbound Logistics
- 12.3 Operations
- 12.4 Outbound Logistics
- 12.5 Marketing and Sales
- 12.6 Service
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies, Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 BGI Genomics Co., Ltd.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Bio-Rad Laboratories, Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Eurofins GSC Lux SARL
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 F. Hoffmann-La Roche Ltd
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 GE Healthcare
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Illumina, Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Gene Technology IP Limited
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.9 Pacific Biosciences of California Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.10 PerkinElmer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 QIAGEN GmbH
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.12 Thermo Fisher Scientific Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
